FIELD: medicine; hepatology.
SUBSTANCE: invention can be used for differential diagnosis of steatosis and non-alcoholic steatohepatitis in females. A patient's vein sample is taken, his biochemical indices are analyzed to determine various forms of non-alcoholic fatty liver disease. Analysis is carried out chromatographically. Analyzed biochemical values are represented by concentration of lactic and oxanilic acid in a blood sample. Ratio of concentrations of said acids to each other is determined. If the ratio of lactic acid to oxanilic acid concentration is 98/1 or less, the patient is diagnosed with steatosis. If ratio is 325/1 and more, the patient is diagnosed with non-alcoholic steatohepatitis. If the ratio ranges from 99/1 to 324/1, the patient is not diagnosed accurately and additional diagnostic measures are taken.
EFFECT: method enables higher accuracy, sensitivity and specificity of diagnosing various forms of non-alcoholic fatty liver disease in females: steatosis and non-alcoholic steatohepatitis, as well as possibility of diagnosing irrespective of various factors of action due to determination of content of carboxylic acids: lactic and oxanilic, in a blood sample by means of gas chromatography-mass-spectrometry.
1 cl, 12 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
METHOD OF DETERMINING THE RISK OF SEVERE LIVER STEATOSIS | 2023 |
|
RU2806496C1 |
METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
METHOD FOR DETERMINATION OF ATHEROSCLEROTIC DAMAGE OF VASCULAR WALL IN PATIENTS WITH ABDOMINAL OBESITY AND NONALCOLORAL FAT LIVER DISEASE (VERSIONS) | 2016 |
|
RU2637412C1 |
SCREENING DIAGNOSING METHOD FOR FATTY LIVER DEGENERATION ACCOMPANYING ABDOMINAL OBESITY | 2018 |
|
RU2684201C1 |
METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765847C1 |
METHOD FOR PREDICTION OF HEPATOTROPHIC THERAPY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2015 |
|
RU2595827C1 |
METHOD FOR TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE USING SPECIALIZED FOOD PRODUCT | 2021 |
|
RU2761164C1 |
MINIMALLY INVASIVE METHOD FOR DIAGNOSING NON-ALCOHOLIC FATTY LIVER DISEASE BASED ON THE IDENTIFICATION OF MIRNAS AND MIP-1β IN BLOOD PLASMA | 2022 |
|
RU2798163C1 |
Authors
Dates
2021-03-02—Published
2020-09-23—Filed